AIM IMMUNOTECH Stock Today

<div class='circular--portrait' style='background:#000000;color: #f2f2f2;font-size:4em;padding-top: 25px;;'>AI</div>
AIM IMMUNOTECH is trading at 2.12 as of the 5th of July 2020, which is 1.92% increase since the beginning of the trading day. The stock's lowest day price was 2.12. AIM IMMUNOTECH has about a 31 percent probability of financial distress in the next few years of operation and has generated negative returns over the last 30 days. Equity ratings for AIM IMMUNOTECH INC are calculated daily based on the scoring framework. The performance scores are derived for the period starting the 6th of April 2020 and ending today, the 5th of July 2020. Click here to learn more.
Analyze Filter   Check how we calculate scores

   Performance
0 100 

   Odds of Distress
31  

AIM IMMUNOTECH Profile

AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers and immune-deficiency disorders in the United States. AIM ImmunoTech Inc. was founded in 1966 and is headquartered in Ocala, Florida. AIM IMMUNOTECH operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. It employs 24 people. more on AIM IMMUNOTECH
Legal NameAIM IMMUNOTECH INC
Macroaxis Advice
Macroaxis buy hold or sell recommendation provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of AIM IMMUNOTECH available fundamental, technical, and predictive indicators. Current horizon is 30 days (very short) - details
AIM IMMUNOTECH INC (HXB2) is traded on Frankfurt Stock Exchange in Germany and employs 24 people. The company currently falls under 'Micro-Cap' category with current market capitalization of 83.16 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate AIM IMMUNOTECH's market, we take the total number of its shares issued and multiply it by AIM IMMUNOTECH's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. AIM IMMUNOTECH INC operates under Healthcare sector and is part of Biotechnology industry. The entity has 32.62 M outstanding shares. The company has accumulated about 28.09 M in cash with (10.67 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.96.
Check AIM IMMUNOTECH Probability Of Bankruptcy

Ownership Allocation (%)

AIM IMMUNOTECH Stock Price Odds Analysis

Odds Down 2.12HorizonTargetOdds Up 2.12
51.75%30 days
 2.12 
48.10%
Based on a normal probability distribution, the odds of AIM IMMUNOTECH to move above the current price in 30 days from now is about 48.1 (This AIM IMMUNOTECH INC probability density function shows the probability of AIM IMMUNOTECH Stock to fall within a particular range of prices over 30 days) .

AIM IMMUNOTECH INC Risk Profiles

AIM IMMUNOTECH Stock Against Markets

Did you try this?

Run Technical Analysis Now

   

Technical Analysis

Check basic technical indicators and analysis based on most latest market data
All  Next Launch Module
Please check Risk vs Return Analysis. Please also try Stock Screener module to find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Company logos by clearbit
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page